Piperacilin/tazobaktam Qilu 4 g/0,5 g prašak za otopinu za infuziju
| Name | Piperacilin/tazobaktam Qilu 4 g/0,5 g prašak za otopinu za infuziju |
|---|---|
| Marketing Authorisation Number | HR-H-878898010 |
| Active Substance | piperacilinnatrij tazobaktamnatrij |
| Composition | svaka bočica sadrži 4 g piperacilina (u obliku piperacilinnatrija) i 0,5 g tazobaktama (u obliku tazobaktamnatrija) |
| Pharmaceutical Form | prašak za otopinu za infuziju |
| Manufacturer | Kymos S.L., Cerdanyola del Valles, Barcelona, Španjolska Unifarma SIA, Riga, Latvija Eurofins Analytical Services Hungary Kft., Budimpešta, Mađarska |
| Marketing Authorisation Holder | Qilu Pharma Spain S.L., Paseo de la Castellana 40, planta 8, Madrid, Španjolska |
| Marketing Authorisation Date | 06.04.2023 |
| MA Period of Validity | 06.04.2028 |
| Classification Number | UP/I-530-09/21-01/113 |
| Registration Number | 381-12-01/171-23-11 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | J01CR05 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
